Search results for "Vancomycin"

showing 10 items of 69 documents

Parietal subdural empyema as complication of acute odontogenic sinusitis: a case report

2014

Introduction: To date intracranial complication caused by tooth extractions are extremely rare. In particular parietal subdural empyema of odontogenic origin has not been described. A literature review is presented here to emphasize the extreme rarity of this clinical entity. Case presentation: An 18-year-old Caucasian man with a history of dental extraction developed dysarthria, lethargy, purulent rhinorrhea, and fever. A computed tomography scan demonstrated extensive sinusitis involving maxillary sinus, anterior ethmoid and frontal sinus on the left side and a subdural fluid collection in the temporal-parietal site on the same side. He underwent vancomycin, metronidazole and meropenem th…

Malemedicine.medical_specialtyAdolescentMaxillary sinusmedicine.medical_treatmentCase ReportSubdural empyemaSubdural SpaceDiagnosis DifferentialIntracranial infections Odontogenic sinusitis Paranasal sinusitis Subdural empyemaVancomycinMetronidazoleParietal LobemedicineHumansSinusitisSubdural spaceSinusitisCraniotomyOdontogenic sinusitisSubdural empyemaMedicine(all)Empyema SubduralFrontal sinusrhinorrheabusiness.industryParanasal sinusitisSettore MED/37 - NeuroradiologiaSequelaMeropenemGeneral MedicineMaxillary Sinusmedicine.diseaseAnti-Bacterial AgentsSurgerySettore MED/32 - AudiologiaTreatment Outcomemedicine.anatomical_structureSettore MED/31 - OtorinolaringoiatriaIntracranial infectionsAcute DiseaseTooth ExtractionThienamycinsmedicine.symptomTomography X-Ray ComputedbusinessCraniotomyFollow-Up Studies
researchProduct

Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.

2011

The aim of this study was to define a two-compartments pharmacokinetic model and to estimate the pharmacokinetic parameters of IP administered vancomycin in patients with continuous ambulatory peritoneal dialysis (CAPD) associated peritonitis. Ten patients with peritoneal dialysis treatment and peritonitis were prospectively enrolled in the study. The empiric treatment is: vancomycin 2 g every 5-7 days and ceftazidime 1500 mg per exchange, once daily. Pharmacokinetic modeling and parameter calculations were carried out using the nonlinear regression. The mean peritoneal concentration 10 min after the first peritoneal exchange of vancomycin free dialysis liquid was 9.5±7.3 μg/ml, showing tha…

Malemedicine.medical_specialtymedicine.medical_treatmentUrologyPharmaceutical SciencePeritonitisPeritonitisCeftazidimePeritoneal dialysisPharmacokineticsPeritoneal Dialysis Continuous AmbulatoryVancomycinmedicineHumansDialysisAntibacterial agentAgedbusiness.industryContinuous ambulatory peritoneal dialysisMiddle Agedmedicine.diseaseSurgeryAnti-Bacterial AgentsAmbulatoryVancomycinFemalebusinessInjections Intraperitonealmedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DAL…

2014

The aims of this study were to describe the variability in protein binding of teicoplanin in critically ill patients as well as the number of patients achieving therapeutic target concentrations. This report is part of the multinational pharmacokinetic DALI Study. Patients were sampled on a single day, with blood samples taken both at the midpoint and the end of the dosing interval. Total and unbound teicoplanin concentrations were assayed using validated chromatographic methods. The lower therapeutic range of teicoplanin was defined as total trough concentrations from 10 to 20 mg/L and the higher range as 10-30 mg/L. Thirteen critically ill patients were available for analysis. The followi…

Malevalidityvalidation proceInternational CooperationSettore MED/41 - Anestesiologiadrug protein bindingGastroenterologylaw.inventionPlasmaStaphylococcus infectionCritically ill patientsInterquartile rangelaw[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesAntibioticsantibiotic therapyPharmacology (medical)Pharmacology & PharmacyAntibiotics; Critically ill patients; Glycopeptides; Hypoalbuminaemia; ICU; Pharmacokinetics; Adult; Aged; Anti-Bacterial Agents; Chromatography; Critical Illness; Female; Humans; International Cooperation; Male; Middle Aged; Plasma; Protein Binding; Teicoplanin; Young Adult; Drug Monitoring; Microbiology (medical); Infectious Diseases; Pharmacology (medical)Antibiotics; Critically ill patients; Glycopeptides; Hypoalbuminaemia; ICU; Pharmacokinetics; Adult; Aged; Anti-Bacterial Agents; Chromatography; Critical Illness; Female; Humans; International Cooperation; Male; Middle Aged; Plasma; Protein Binding; Teicoplanin; Young Adult; Drug Monitoringclinical articleChromatographymedicine.diagnostic_testdrug dose regimencritical illneTeicoplaninHypoalbuminaemiaMedicine (all)articleGlycopeptidesclinical trialGeneral MedicineMiddle Agedtrough time concentrationdrug protein binding variabilityIntensive care unitGlycopeptides Antibiotics Critically ill patients Pharmacokinetics Hypoalbuminaemia ICU3. Good healthAnti-Bacterial Agentsantiinfective agentdrug distributionInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitologypriority journalmulticenter study (topic)Vancomycinblood samplingFemaleCritically ill patientDrug MonitoringHumanmedicine.drugProtein BindingMicrobiology (medical)Adultmedicine.medical_specialtyhigh performance liquid chromatographyarea under the curveCritical Illnessultraviolet spectroscopymid dose concentrationchemistryGlycopeptideMicrobiologyteicoplanin adultenterococcal infectionyoung adult Adultdrug clearanceYoung AdultTherapeutic indexPharmacokineticsInternal medicineAnti-Bacterial AgentmedicineHumanssteady statePharmacokineticsDosingAgedbusiness.industrydrug half lifeAntibioticrecommended drug doseAntibiotics; Critically ill patients; Glycopeptides; Hypoalbuminaemia; ICU; Pharmacokinetics; Adult; Aged; Anti-Bacterial Agents; Chromatography; Critical Illness; Female; Humans; International Cooperation; Male; Middle Aged; Plasma; Protein Binding; Teicoplanin; Young Adult; Drug Monitoring; Microbiology (medical); Infectious Diseases; Pharmacology (medical); Medicine (all)calibrationSurgerymulticenter studyTherapeutic drug monitoringdrug blood levelICU[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacologyfree plasma drug concentrationTeicoplaninbusinessmetabolism
researchProduct

Mechanical, degradation and drug-release behavior of nano-grained Fe-Ag composites for biomedical applications.

2018

Abstract An original fabrication route of high-strength bulk Fe-5Ag and Fe-10Ag nanocomposites with enhanced degradation rate is reported. Near fully dense materials with fine nanostructures and uniform distribution of Ag nanoparticles were obtained employing high energy attrition milling of Fe-Ag2O powder blends followed by cold sintering – high pressure consolidation at ambient temperature that allowed the retention of the nanoscale structure. Annealing in hydrogen flow at 550 °C resulted in enhanced ductility without coarsening the nanostructure. The strength in compression of Fe5Ag and Fe10Ag nanocomposites was several-fold higher than the values reported for similar composites with mic…

Materials scienceNanostructureHot TemperatureSilverAnnealing (metallurgy)Cell SurvivalIronBiomedical EngineeringSinteringMetal Nanoparticles02 engineering and technology010402 general chemistry01 natural sciencesCorrosionBiomaterialsFlexural strengthVancomycinNano-ElectrochemistryHumansComposite materialMechanical PhenomenaDrug CarriersNanocompositeOsteoblasts021001 nanoscience & nanotechnologyGrain size0104 chemical sciencesCorrosionDrug LiberationMechanics of Materials0210 nano-technologyJournal of the mechanical behavior of biomedical materials
researchProduct

Expanding spectrum of illness due to community-associated methicillin-resistant Staphylococcus aureus: a case report

2009

Introduction Xanthogranulomatous pyelonephritis is a rarely identified form of chronic pyelonephritis usually caused by gram-negative organisms. Herein, we report the first case caused by infection due to community-associated methicillin-resistant Staphylococcus aureus strain. Case presentation An HIV-infected female with a history of intravenous drug use presented with a three month history of abdominal pain, distension, and fever. Computerized tomography of the abdomen revealed a large multicystic right kidney mass. During surgical exploration an intrarenal abscess was identified. Cultures revealed the presence of community-associated methicillin-resistant Staphylococcus aureus. Histopath…

Medicine(all)medicine.medical_specialtyAbdominal painPathologymedicine.drug_classbusiness.industrymedicine.medical_treatmentAntibioticsGeneral Medicinemedicine.disease_causemedicine.diseaseMethicillin-resistant Staphylococcus aureusNephrectomychemistry.chemical_compoundchemistryStaphylococcus aureusInternal medicineLinezolidCase reportmedicineVancomycinmedicine.symptomAbscessbusinessmedicine.drugCases Journal
researchProduct

In vitro anti-Gram-positive and anti-staphylococcal biofilm activity of newly halogenated pyrroles related to Pyrrolomycins

2007

Microbiology (medical)ChemistryStaphylococcusBiofilmGeneral MedicineMicrobial Sensitivity Testshalogenated pyrroleGram-Positive Bacteriaantistaphylococcal biofilm activityIn vitroMicrobiologyAnti-Bacterial AgentsStructure-Activity RelationshipInfectious DiseasesVancomycinBiofilmsStructure–activity relationshipPharmacology (medical)PyrrolespyrrolomycinsGram
researchProduct

Toxic Effect of Vancomycin on Viability and Functionality of Different Cells Involved in Tissue Regeneration

2020

To prevent infections local delivery of antibiotics is a useful tool. Especially in bone fractures, vancomycin impregnated bone cements are often used allowing high concentrations of antibiotics at the infection side without high serum concentrations. However, besides potential pathogens, cells involved in tissue regeneration may also be affected by the drug. We investigated the effect of vancomycin on the viability and functionality on osteoblasts, endothelial cells, fibroblasts and skeletal muscle cells. Our results show that the viability of all cells analyzed was reduced by vancomycin and that the observed effects were time and concentration dependent. The most pronounced toxic effect w…

Microbiology (medical)Druglocal antibioticsmedicine.drug_classCellular differentiationmedia_common.quotation_subjectAntibioticsvancomycintissue regenerationPharmacologyBiochemistryMicrobiologyArticle03 medical and health sciences0302 clinical medicinemedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsCell survivalmedia_common030222 orthopedicsChemistryCell growthlcsh:RM1-950Skeletal muscleConcentration dependentcell differentiationInfectious Diseasesmedicine.anatomical_structurelcsh:Therapeutics. Pharmacologycell proliferationVancomycin030217 neurology & neurosurgerymedicine.drugAntibiotics
researchProduct

VanB-VanC1 Enterococcus gallinarum, Italy

2005

To the Editor: We report detecting a vanB determinant in Enterococcus gallinarum in poultry in Italy. High-level vanA-mediated glycopeptide resistance has been described for E. gallinarum and E. casseliflavus (1–4), and vanB-mediated vancomycin resistance has been frequently described for E. faecalis and E. faecium. However, vanB-mediated resistance in isolates of E. gallinarum has been described only in sporadic nosocomial cases of infection or colonization (5,6). In January 2005, a study of contamination by foodborne organisms in slaughtered broiler carcasses was conducted in Sicily. To detect glycopeptide-resistant enterococci (GRE), each carcass was placed in a bag with 100 mL sterile b…

Microbiology (medical)Epidemiologyeducationletterlcsh:MedicineMicrobial Sensitivity TestsEnteococcus gallinarum; vanB-vanC1lcsh:Infectious and parasitic diseasesMicrobiologychemistry.chemical_compoundEnterococcus gallinarumBacterial ProteinsMultiplex polymerase chain reactionmedicineAnimalsmedia_common.cataloged_instancelcsh:RC109-216Peptide SynthasesEuropean unionLetters to the Editormedia_commonbiologyTeicoplaninpoultryEnterococcus gallinarumlcsh:RAvoparcinVancomycin Resistancebiochemical phenomena metabolism and nutritionvancomycin-resistant enterococcibacterial infections and mycosesbiology.organism_classificationGlycopeptideInfectious DiseasesEnterococcuschemistryItalyVancomycinvanB-vanC1ChickensEnterococcusmedicine.drug
researchProduct

Occurence of vancomycin-resistant Enterococcus faecium in patient isolates and aquatic environment during a period between 2004 and 2010

2012

Microbiology (medical)Infectious DiseasesAquatic environmentPeriod (gene)educationIn patientGeneral MedicineBiologyMicrobiologyVancomycin resistant Enterococcus faeciumInternational Journal of Infectious Diseases
researchProduct

Intra- and Interinstitutional Evaluation of an Etest for Vancomycin Minimum Inhibitory Concentration Measurement inStaphylococcus aureusBlood Isolate…

2015

Microbiology (medical)Minimum inhibitory concentrationInfectious Diseasesbusiness.industryStaphylococcus aureusmedicineVancomycinbusinessmedicine.disease_causeEtestMicrobiologymedicine.drugMinimum Inhibitory Concentration measurementClinical Infectious Diseases
researchProduct